Introducing TYBR Spray
Transforming post-operative recovery through regenerative medicine solutions
Adhesions are internal scars that damage vital organs.
Emergency Surgery Admissions
Chronic Abdominal Pain Cases
Spending on complications from adhesions
1 in 4
25% of patients who undergo abdominal or pelvic surgeries will be admitted for complications from adhesions
How does TYBR Spray work?
Extracellular Matrix Technology
Proprietary material that reduces adhesions and improves the healing response of tissue.
Delivered through a simple and steerable device.
TYBR Health, Inc. was formed out of the Texas Medical Center (TMC) Biodesign fellowship in 2020. Over the course of 1 year, the team identified a clinical problem, created a solution, and started a company. The team met for the first time on day 1 of the program, and as of July 2020 will continue forward, not as fellows, but as co-founders of TYBR Health.
Tim Keane, PhD
Tim Keane is bioengineer and extracellular matrix expert. Prior to co-founding TYBR, he was a Post-Doctoral Fellow at Imperial College London where he designed and tested biomaterials to enhance tissue healing following injury. He holds a BSc in Chemical Engineering and PhD in Bioengineering from the University of Pittsburgh. He is co-inventor on 7 filed patents and has authored over 25 peer-reviewed publications garnering 1600+ citations.
Stephen is a bioengineer and M.D. candidate. He graduated with a BSc in Biomedical Engineering from University of Virginia, and is currently completing his final year of medical school. During his time at U.Va, he conducted prototype testing for medical devices, built mechatronic components for orthopedic devices at the Hospital for Special Surgery, and participated in the Darden School of Business Incubator program.
Alex Smith, PhD
Alex Smith is a mechanical engineer who holds a B.Sc. and M.Eng. in Biomedical Engineering from Texas A&M University and a PhD in Mechanical Engineering from University of Houston and the Texas Heart Institute. He previously created a new ported graft to enable reliable and consistent hemodialysis access for Sceptre Medical. At the Texas Heart Institute, he also designed a minimally invasive partial support left ventricular assist device to treat early-stage heart failure.